Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Carolin Loos, Ph.D.

Co-Author

This page shows the publications co-authored by Carolin Loos and Galit Alter.
Connection Strength

4.240
  1. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity. mSphere. 2020 09 02; 5(5).
    View in: PubMed
    Score: 0.918
  2. Dissecting the antibody-OME: past, present, and future. Curr Opin Immunol. 2020 08; 65:89-96.
    View in: PubMed
    Score: 0.913
  3. Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination. Cell Rep Med. 2021 Sep 21; 2(9):100405.
    View in: PubMed
    Score: 0.246
  4. Functional Antibodies in COVID-19 Convalescent Plasma. medRxiv. 2021 Mar 11.
    View in: PubMed
    Score: 0.238
  5. Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination. Res Sq. 2021 Feb 15.
    View in: PubMed
    Score: 0.237
  6. Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination. bioRxiv. 2021 Feb 05.
    View in: PubMed
    Score: 0.236
  7. Compromised SARS-CoV-2-specific placental antibody transfer. Cell. 2021 02 04; 184(3):628-642.e10.
    View in: PubMed
    Score: 0.235
  8. Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality. Cell. 2020 12 10; 183(6):1508-1519.e12.
    View in: PubMed
    Score: 0.232
  9. SARS-CoV-2-specific ELISA development. J Immunol Methods. 2020 Sep - Oct; 484-485:112832.
    View in: PubMed
    Score: 0.228
  10. Distinct Early Serological Signatures Track with SARS-CoV-2 Survival. Immunity. 2020 09 15; 53(3):524-532.e4.
    View in: PubMed
    Score: 0.228
  11. Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination. Med (N Y). 2021 Jun 11; 2(6):701-719.e19.
    View in: PubMed
    Score: 0.061
  12. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. JAMA. 2021 04 20; 325(15):1535-1544.
    View in: PubMed
    Score: 0.060
  13. Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2. JCI Insight. 2021 03 22; 6(6).
    View in: PubMed
    Score: 0.060
  14. Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features. mBio. 2021 03 09; 12(2).
    View in: PubMed
    Score: 0.059
  15. Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. 2021 Feb; 590(7844):E25.
    View in: PubMed
    Score: 0.059
  16. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature. 2021 02; 590(7847):630-634.
    View in: PubMed
    Score: 0.058
  17. Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters. Nat Med. 2020 11; 26(11):1694-1700.
    View in: PubMed
    Score: 0.057
  18. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. 2020 10; 586(7830):583-588.
    View in: PubMed
    Score: 0.057
  19. DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science. 2020 08 14; 369(6505):806-811.
    View in: PubMed
    Score: 0.056
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.